CA – AACE Diabetes Day for Primary Care Providers

Saturday, November 9, 2013
7:00 - 7:50 am Continental Breakfast
7:50 - 8:00 am Welcome Remarks & Objectives Review
Laurence Gavin, MD, FRCP, FACP, FACE - Local Program Chair
8:00 - 8:10 am Pre-Test
Educational Objectives
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:10 - 8:40 am The Obesity Epidemic and Type 2 Diabetes
Jyoti Bhat, MD
Educational Objectives
  1. Identify patients at risk for prediabetes and diabetes.
  2. Describe the different methods available to diagnose type 2 diabetes.
  3. Select appropriate treatment goal and assess different classes of therapeutic agents designed to treat specific diabetic pathophysiologic defects.
  4. Describe new strategies for weight management in patient with obesity.
8:40 - 8:50 am Q&A
8:50 - 9:30 am New Paradigm in Management of Type 2 Diabetes
William Zigrang, MD, CCD, FACE
Educational Objectives
  1. Outline the clinical considerations in the selection of pharmacotherapy for type 2 diabetes, including degree of A1C lowering needed, patient specific concerns, adverse effects, comorbidities, and contraindications.
  2. Discuss the role of combination therapy and when it should be initiated based on A1C goals.
  3. Select appropriate classes of therapeutic agents designed to treat specific diabetic pathophysiologic defects, including whether or not they can be used as part of mono- or combination-therapy strategies.
9:30 - 9:40 am Q&A
9:40 - 10:10 am Break
10:10 - 10:45 am Where Do GLP-1 Receptor Agonists and DPP4 inhibitors fit into Diabetes Treatment Algorithm?
Laurence Gavin, MD, FRCP, FACP, FACE
Educational Objectives
  1. Compare the clinical differences between GLP-1 receptor agonists and DPP4 inhibitors and alternative antihyperglycemic agents as therapeutic options after metformin failure.
  2. Assess the clinical data and different profiles of currently available GLP-1 receptor agonists and DPP4 Inhibitors.
  3. Review the most current data on the clinical benefits of GLP-1 receptor agonists and DPP4 Inhibitors beyond glucose control.
10:45 - 10:55 am Q&A
10:55 - 11:30 am Successful Transition to Insulin Replacement Therapy in Type 2 Diabetes
David A. Chappell, MD
Educational Objectives
  1. Select strategies how to introduce insulin to patients who are candidates for this therapy.
  2. Describe the current and emerging insulin therapies for the treatment of type 2 diabetes.
  3. Describe how to intensify insulin regimen to achieve glycemic targets.
  4. Examine available insulin modalities (vials, devices) for delivery and their use in the outpatient setting.
  5. Examine the novel use of GLP-1 analogue and insulin combination.
11:30 - 11:40 am Q&A
11:40 - 12:20 pm Case Presentations: Management of Diabetes, Applying Science to Practice
All Faculty Panel Discussion

Educational Objectives
  1. Summarize steps on how to apply the knowledge gained from this activity to the learners practice to improve and document the disease management outcomes for patients with type 2 diabetes.
12:20 - 12:30 pm Post-test
Educational Objectives
  1. Attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
12:30 pm Adjourn

California-AACE Diabetes Day for Primary Care Providers
Saturday, November 9, 2013

Hyatt Regency San Francisco
Five Embarcadero Center
San Francisco, CA 94111

Program Planning Committee:
Chris K. Guerin, MD, FNLA, FACE, Program Planning Committee Co-Chair
Etie Moghissi, MD, FACP, FACE, Program Planning Committee Co-Chair
Timothy S. Bailey, MD, FACP, FACE, ECNU, CPI; CA AACE President
*Laurence Gavin, MD, FRCP, FACP, FACE - Local Program Chair

*Indicates both a member of the Program Planning Committee and faculty.

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Association of Clinical Endocrinologists (AACE) and the California Chapter of AACE. The AACE is accredited by the ACCME to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Supporters:
Corporate supporters will be listed in the program syllabus.

The material presented during the California Chapter of AACE meeting is being made available by the California Chapter of AACE for educational purposes only, and does not necessarily represent the only or best method or procedure appropriate for the medical situations discussed. The opinions and views expressed represent the opinions of the presenters and not necessarily those of the California Chapter of AACE, AACE, or its governing body. Therefore, the California Chapter of AACE and AACE disclaim any and all liability for injury or other damages resulting to an individual attending this meeting or to any third party for claims based upon the use of techniques and/or products presented by any party at this meeting.

Target Audience:
Primary care providers, allied health professionals and other interested healthcare professionals in California.

Registration is complimentary for all attendees.

Onsite registration will be available on Saturday, November 9, 2013 at the Hyatt Regency San Francisco in the Bayview Foyer.


AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources


AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.